Ironwood Pharmaceuti (IRWD)
$1.27 -0.07 (-5.22%)| Market Cap | 230.44M |
| Revenue (ttm) | 351.41M |
| Net Income (ttm) | 1.81M |
| EPS (ttm) | N/A |
| PE Ratio | 70.50 |
| Forward PE | 6.96 |
| Profit Margin | 0.52% |
| Debt to Equity Ratio | -1.28 |
| Volume | 3,065,100 |
| Avg Vol | 3,514,006 |
| Day's Range | N/A - N/A |
| Shares Out | 160.03M |
| Stochastic %K | 19% |
| Beta | 0.30 |
| Analysts | Strong Sell |
| Price Target | $8.67 |
Latest News on IRWD
Mar 27, 2025, 4:05 PM EDT - 11 days ago
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
Mar 25, 2025, 8:30 AM EDT - 13 days ago
Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund
Feb 27, 2025, 11:21 AM EST - 5 weeks ago
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript
Feb 27, 2025, 7:00 AM EST - 5 weeks ago
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
Feb 20, 2025, 4:00 PM EST - 6 weeks ago
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Jan 29, 2025, 4:05 PM EST - 2 months ago
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
Jan 17, 2025, 8:07 AM EST - 2 months ago
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Nov 26, 2024, 4:01 PM EST - 4 months ago
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 13, 2024, 4:01 PM EST - 5 months ago
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Nov 7, 2024, 10:34 PM EST - 5 months ago
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript
Oct 24, 2024, 4:00 PM EDT - 5 months ago
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
Aug 29, 2024, 4:01 PM EDT - 7 months ago
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
Aug 9, 2024, 12:10 PM EDT - 8 months ago
Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript
Aug 8, 2024, 7:00 AM EDT - 8 months ago
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
Jul 25, 2024, 4:00 PM EDT - 9 months ago
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
Jun 28, 2024, 11:00 AM EDT - 10 months ago
The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation
Jun 26, 2024, 3:30 PM EDT - 10 months ago
The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue
Jun 25, 2024, 2:45 PM EDT - 10 months ago
The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact
Jun 24, 2024, 4:45 PM EDT - 10 months ago
The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication
Jun 23, 2024, 11:00 AM EDT - 10 months ago
The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect
Jun 22, 2024, 11:00 AM EDT - 10 months ago
The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out
Jun 19, 2024, 4:20 PM EDT - 10 months ago
Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact
Jun 18, 2024, 4:00 PM EDT - 10 months ago
Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out
Jun 11, 2024, 7:00 PM EDT - 10 months ago
Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out
Jun 9, 2024, 11:00 AM EDT - 10 months ago
Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them
Jun 8, 2024, 11:00 AM EDT - 10 months ago
Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch
Jun 7, 2024, 3:00 PM EDT - 10 months ago
Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them
Jun 6, 2024, 1:00 PM EDT - 10 months ago
Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out
Jun 5, 2024, 1:30 PM EDT - 10 months ago
Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect
Jun 4, 2024, 3:00 PM EDT - 10 months ago
The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out
May 30, 2024, 4:01 PM EDT - 11 months ago
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 9, 2024, 5:54 PM EDT - 11 months ago
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2024 Earnings Call Transcript
May 9, 2024, 7:00 AM EDT - 11 months ago
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
May 6, 2024, 4:01 PM EDT - 1 year ago
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
Apr 25, 2024, 4:01 PM EDT - 1 year ago
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
